|
Tuesday, May 19, 2015 3:09 AM
|
CCSVI in Multiple Sclerosis
An essay by Dr Helen Kavnoudias on The Alfred CCSVI in Multiple Sclerosis project in Australia. "42 people with MS and venous abnormalities were treated in a pre-trial at The Alfred in 2010 and patients reported improvements in vision, mobility, balance, fatigue, cognition and heat tolerance amongst other things. Such functional improvements were reported that people were returning to full time work and made decisions to start families. This was enough evidence to warrant further investigation. However, in the meantime access to this treatment has been halted…" …and the research continues, Kerri http://brainfoundation.org.au/wp-content/uploads/2015/05/Kavnoudias-Helen-Multiple-Sclerosis-.pdfbrainfoundation.org.aubrainfoundation.org.au
|